13 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Green smoothies, the hearty drink with a health halo https://www.nrn.com/consumer-trends/green-smoothies-hearty-drink-health-halo Apr 04, 2024 - Green smoothies can vary widely in ingredients, but the core component is usually a leafy green vegetable. It’s usually spinach or kale, but it could also include the fleshy leaves of the aloe vera plant or other nutrient-dense greens. Those are puré
Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2213449/why-halozyme-therapeutics-halo-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2213449 Jan 22, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates https://www.zacks.com/stock/news/2270054/halozyme-therapeutics-halo-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2270054 May 07, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2274099/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2274099 May 15, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2195473/why-halozyme-therapeutics-halo-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2195473 Dec 08, 2023 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO) https://www.zacks.com/stock/news/2198208/3-reasons-growth-investors-will-love-halozyme-therapeutics-halo?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2198208 Dec 14, 2023 - Halozyme Therapeutics (HALO) possesses solid growth attributes, which could help it handily outperform the market.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2205005/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2205005 Jan 03, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release https://www.zacks.com/stock/news/2225551/halozyme-therapeutics-halo-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2225551 Feb 13, 2024 - Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release https://www.zacks.com/stock/news/2226264/exact-sciences-exas-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2226264 Feb 14, 2024 - Exact Sciences (EXAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compared to Estimates, Halozyme Therapeutics (HALO) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2228804/compared-to-estimates-halozyme-therapeutics-halo-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228804 Feb 20, 2024 - The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pages: 12

Page 1